Breaking News, Financial News

Financial Report: BASi 1Q

Service revenue was $6.0 million in the quarter (-25%). Product revenue was $2.0 million (-16%). Loss from continuing operations was $2.0 million.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

BASi 1Q Revenues: $8.1 million (-24%) 1Q Loss: $1.6 million (loss of $16,000 1Q08) Comments: Service revenue was $6.0 million in the quarter (-25%). Product revenue was $2.0 million (-16%). Loss from continuing operations was $2.0 million. The company sold and its Baltimore, MD clinic in June 2008 and discontinued its Phase I clinical trials business. The loss from discontinued operations was $603,000 in 1Q07. According to the company, several projects were delayed or cancelled in the...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters